Bedell Frazier Investment Counselling’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13M Sell
53,183
-6,957
-12% -$1.62M 2.63% 5
2025
Q4
$12.4M Buy
60,140
+1,338
+2% +$265K 2.4% 7
2025
Q3
$10.9M Sell
58,802
-1,380
-2% -$236K 2.24% 8
2025
Q2
$9.19M Buy
60,182
+31
+0.1% +$4.76K 2.31% 15
2025
Q1
$9.98M Sell
60,151
-10,111
-14% -$1.58M 2.54% 10
2024
Q4
$10.2M Sell
70,262
-6,373
-8% -$988K 2.52% 9
2024
Q3
$12.4M Sell
76,635
-739
-1% -$118K 2.97% 8
2024
Q2
$11.3M Buy
77,374
+1,151
+2% +$171K 2.73% 9
2024
Q1
$12.1M Sell
76,223
-678
-0.9% -$108K 3.01% 7
2023
Q4
$12.1M Sell
76,901
-770
-1% -$118K 3.32% 7
2023
Q3
$12.1M Sell
77,671
-318
-0.4% -$52.5K 3.61% 6
2023
Q2
$12.9M Sell
77,989
-3,775
-5% -$609K 3.78% 6
2023
Q1
$12.7M Buy
81,764
+2,307
+3% +$373K 3.71% 7
2022
Q4
$14M Buy
79,457
+220
+0.3% +$38K 3.67% 6
2022
Q3
$12.9M Buy
79,237
+10,924
+16% +$1.85M 3.64% 5
2022
Q2
$12.1M Buy
68,313
+2,295
+3% +$409K 3.72% 6
2022
Q1
$11.7M Buy
66,018
+4,039
+7% +$687K 2.96% 7
2021
Q4
$10.6M Buy
61,979
+404
+0.7% +$66.1K 2.58% 8
2021
Q3
$9.94M Sell
61,575
-731
-1% -$125K 2.73% 6
2021
Q2
$10.3M Buy
62,306
+783
+1% +$130K 2.6% 7
2021
Q1
$10.1M Buy
61,523
+9,036
+17% +$1.46M 2.86% 6
2020
Q4
$8.26M Buy
52,487
+3,553
+7% +$524K 2.53% 8
2020
Q3
$7.29M Buy
48,934
+244
+0.5% +$36.1K 2.6% 8
2020
Q2
$6.85M Buy
48,690
+99
+0.2% +$14.4K 2.76% 10
2020
Q1
$6.37M Buy
48,591
+25
+0.1% +$3.55K 2.99% 11
2019
Q4
$6.28M Hold
48,566
2.52% 16
2019
Q3
$6.28M Buy
48,566
+43,402
+840% +$5.72M 2.45% 16
2019
Q2
$719K Buy
5,164
+650
+14% +$90K 0.26% 36
2019
Q1
$631K Buy
4,514
+171
+4% +$22.9K 0.25% 38
2018
Q4
$560K Buy
4,343
+345
+9% +$48.1K 0.24% 35
2018
Q3
$552K Hold
3,998
0.15% 48
2018
Q2
$485K Hold
3,998
0.14% 45
2018
Q1
$512K Sell
3,998
-195
-5% -$26.4K 0.18% 40
2017
Q4
$586K Hold
4,193
0.22% 35
2017
Q3
$545K Sell
4,193
-60
-1% -$7.95K 0.25% 32
2017
Q2
$563K Buy
4,253
+95
+2% +$12.1K 0.21% 37
2017
Q1
$518K Buy
4,158
+325
+8% +$38.8K 0.2% 37
2016
Q4
$442K Sell
3,833
-500
-12% -$57.8K 0.17% 42
2016
Q3
$512K Sell
4,333
-62,758
-94% -$7.61M 0.21% 39
2016
Q2
$8.04M Sell
67,091
-2,119
-3% -$241K 3.98% 6
2016
Q1
$7.49M Sell
69,210
-2,050
-3% -$212K 3.87% 8
2015
Q4
$7.32M Sell
71,260
-560
-0.8% -$56.3K 3.63% 9
2015
Q3
$6.7M Buy
71,820
+2,740
+4% +$265K 3.88% 7
2015
Q2
$6.73M Buy
69,080
+5,400
+8% +$541K 2.68% 8
2015
Q1
$6.41M Buy
63,680
+59,030
+1,269% +$6M 2.66% 8
2014
Q4
$486K Buy
4,650
+37
+0.8% +$3.9K 0.24% 45
2014
Q3
$492K Buy
4,613
+313
+7% +$32.5K 0.23% 45
2014
Q2
$450K Sell
4,300
-44,087
-91% -$4.46M 0.23% 42
2014
Q1
$4.75M Sell
48,387
-2,625
-5% -$243K 2.66% 17
2013
Q4
$4.67M Sell
51,012
-12,575
-20% -$1.16M 2.19% 18
2013
Q3
$5.51M Sell
63,587
-1,214
-2% -$109K 2.65% 8
2013
Q2
$5.96M Buy
+64,801
New +$5.5M 2.96% 7

Other funds holding JNJ

Bedell Frazier Investment Counselling's JNJ Position: Q1 2026 in Review

Bedell Frazier Investment Counselling reduced its Johnson & Johnson (JNJ) stake by 12% in Q1 2026, selling an estimated $1.62M and leaving 53,183 shares worth $13M. The position accounts for 2.63% of the portfolio, ranked #5.

Bedell Frazier Investment Counselling first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $14M in Q4 2022. 4,631 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Bedell Frazier Investment Counselling held 53,183 shares of Johnson & Johnson worth $13M as of Q1 2026.
  • Bedell Frazier Investment Counselling sold 6,957 Johnson & Johnson shares in Q1 2026, an estimated $1.62M.
  • Johnson & Johnson made up 2.63% of Bedell Frazier Investment Counselling's portfolio in Q1 2026, its #5 holding.
  • Bedell Frazier Investment Counselling first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Bedell Frazier Investment Counselling's Johnson & Johnson position peaked at $14M in Q4 2022.
  • 4,631 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Bedell Frazier Investment Counselling's 13F filing for Q1 2026, filed 15 May 2026.